Lakewood, CO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. (KRTL) (OTC: KRTL) ("KRTL Holding" or the "Company") today announced that its majority-owned subsidiary, KRTL Biotech, Inc., is ...
This Collection invites perspectives on the historical, socio-cultural and bio-medical facets of anti-infectives, including failure and success stories of anti-infective drugs, a discourse of ...
Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed ...
Antimicrobial stewardship (AMS) refers to coordinated strategies for the targeted, evidence-based, and safe use of ...
The anti-infective drug market is seeing strong growth due to multiple interrelated factors. One key driver is the rising incidence of specific infectious diseases, including healthcare-associated ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today a ...
Basilea Pharmaceutica is hoping to have better luck in its second attempt to build out its anti-infective pipeline, handing over $2 million for Gravitas Therapeutics’ clinical-stage antifungal.
The bad news rippled through the well manicured office park in Lexington, Mass., and settled somewhere on Jeff Alder's desk in January 2002. Cubist, a drug development company focusing on creating ...
The FDA approved the injectable drug ceftobiprole medocaril sodium (Zevtera) to treat adults with Staphylococcus aureus bacteremia (SAB), the agency announced Wednesday. The antibiotic prodrug is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback